PHASE III STUDY COMPARING BEVACIZUMAB PLUS ERLOTINIB TO ERLOTINIB IN PATIENTS WITH UNTREATED NSCLC HARBORING ACTIVATING EGFR MUTATIONS: NEJ026
Naoki Furuya, Tatsuro Fukuhara, Haruhiro Saito, Kana Watanabe, Shunichi Sugawara, Shunichiro Iwasawa, Yoshio Tsunezuka, Ou Yamaguchi, Morihito Okada, Kouzou Yoshimori, Ichiro Nakachi, Akihiko Gemma, Koichi Azuma, Koichi Hagiwara, Toshihiro Nukiwa, Satoshi Morita, Kunihiko Kobayashi, Makoto Maemondo
North East Japan Study Group; Division of Respiratory Medicine, Department of Internal Medicine
Meeting: 2018 ASCO Annual Meeting Track: Lung Cancer–Non-Small Cell Metastatic Abstract number: 9006 Citation: J Clin Oncol 36, 2018 (suppl; abstr 9006) Authors: Naoki Furuya, Tatsuro Fukuhara, Haruhiro Saito, Kana Watanabe, Shunichi Sugawara, Shunichiro Iwasawa, Yoshio Tsunezuka, Ou Yamaguchi, Morihito Okada, Kouzou Yoshimori, Ichiro Nakachi, Akihiko Gemma, Koichi Azuma, Koichi Hagiwara,...